Group 1 - Shenzhen Beixin Life Technology Co., Ltd. focuses on cardiovascular precision intervention solutions, addressing urgent clinical needs and competing with international innovative products [1] - The company has achieved significant milestones, including the first approved FFR system and the first domestically developed 60MHz IVUS system in China, filling gaps in domestic offerings [1] - Beixin Life has established a comprehensive chain for the independent research, production, and commercialization of high-end active interventional devices and consumables, achieving process localization and international quality standards [1] Group 2 - Beixin Life has received multiple recognitions, including being named a national "Little Giant" enterprise and a high-tech enterprise, with an increasing export share of high-end Class III medical devices [2] - The FFR system received EU MDD certification in March 2020, and the IVUS system is expected to receive EU MDR certification in May 2024, showcasing the company's innovation in medical devices [2] - The company has obtained over 20 Class III medical device registrations and more than 80 authorized invention patents, serving over 1,500 hospitals in more than 50 countries [2] Group 3 - Beixin Life was recognized in the "2024 Chuangyebang 100 Future Unicorn" list, highlighting its innovation capabilities and growth prospects in the high-performance medical device sector [3] - The company aims to continue its leadership in intelligent cardiovascular precision intervention solutions, enhancing product quality and services to improve patient health globally [3] - Beixin Life is committed to fostering the global competitiveness of China's high-performance medical device industry [3]